Metered-dose inhaler propellants have contributed a rising amount to greenhouse gases in the U.S. Emissions per inhaler ...

Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and ...

Changxi Pharma & Huadong Medicine enter commercialization collaboration on the improved respiratory system drug CXG87: Hangzhou, China Friday, October 10, 2025, 11:00 Hrs [IST] Ha ...

As reliever monotherapy for mild asthma, the inhaled corticosteroid (ICS)-formoterol combination reduced asthma attacks in children compared with a short-acting β₂-agonist (SABA), the CARE trial ...

The risk for a severe exacerbation was decreased among patients with asthma using high-dose ICS/LABA vs medium-dose ICS/LABA.

The 2018 Lancet Commission,1 After asthma: redefining airways diseases, made clear recommendations to improve outcomes for ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated.

Interferon lambda concentrations in nasal lining fluid fell in or above the predicted therapeutic range with a nasally ...

Please provide your email address to receive an email when new articles are posted on . The risk for severe exacerbations in mild asthma dropped with use of Airsupra vs. albuterol alone in the phase ...

A new study found that a 2-in-1 anti-inflammatory inhaler reduced asthma attacks in children by 45% compared to the ...

From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! Three Pennsylvania cities were recently ranked among the worst in the country for ...

Martin Whyte does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...